NASDAQ : BVS

Bioventus Inc. — Financial statements

Healthcare · Medical Devices · United States

Last price 14.87 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.25B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Bioventus Inc. (BVS) reported revenue of 581.85M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue581.85M568.09M573.28M512.35M512.12M430.90M
Cost of Revenue182.40M179.93M185.05M184.15M181.04M128.19M
Gross Profit399.45M388.16M388.23M328.19M331.08M302.71M
Selling, General & Admin322.42M313.98M330.00M303.88M332.13M254.25M
Research & Development11.57M12.11M13.95M13.45M23.85M19.04M
Operating Expenses338.84M331.81M351.60M326.17M365.74M281.65M
Operating Income60.61M56.34M36.63M2.03M-34.66M21.05M
Interest Expense-19.88M-26.49M-38.79M-40.68M-18.42M-3.84M
Interest & Investment Income6.40M2.73M
Earnings From Equity Investments-1.87M
Currency Exchange Gain (Loss)3.99M1.98M1.31M351.00K-250.00K-132.00K
Other Non Operating Income (Expenses)-3.43M-3.43M339.00K939.00K765.00K1.91M
EBT Excluding Unusual Items41.29M28.40M-520.00K-37.36M-46.16M19.85M
Merger & Restructuring Charges-2.27M-2.23M52.00K-840.00K-6.78M-2.49M
Impairment of Goodwill-124.70M
Gain (Loss) on Sale of Investments-10.29M-7.04M
Gain (Loss) on Sale of Assets1.00K-81.00K-292.00K-3.58M
Asset Writedown-36.36M-78.61M
Legal Settlements-56.00K-51.00K-13.80M
Other Unusual Items-326.00K-326.00K-1.42M-719.00K-1.10M-829.00K
Pretax Income38.64M25.71M-52.34M-121.11M-189.03M9.49M
Income Tax Expense-22.84M-1.56M-5.29M85.00K-44.37M-1.97M
Earnings From Continuing Operations61.48M27.27M-47.05M-121.20M-144.65M11.45M
Earnings From Discontinued Operations-59.49M-54.78M-1.87M
Net Income to Company61.48M27.27M-47.05M-180.69M-199.44M9.59M
Minority Interest in Earnings-7.01M-4.54M10.92M24.46M40.73M9.79M
Net Income54.46M22.73M-36.12M-156.23M-158.70M19.38M
Preferred Dividends & Other Adjustments25.98M
Net Income to Common54.46M22.73M-36.12M-156.23M-158.70M-6.60M
Shares Outstanding (Basic)67.29M66.62M64.55M62.65M61.39M45.47M
Shares Outstanding (Diluted)69.75M68.91M64.55M62.65M61.39M45.47M
EPS (Basic)0.810.34-0.56-2.49-2.59-0.15
EPS (Diluted)0.780.33-0.56-2.49-2.59-0.15
Free Cash Flow94.29M72.11M37.79M7.98M-25.06M9.47M
Free Cash Flow Per Share1.351.050.580.13-0.410.21
Gross Margin68.65%68.33%67.72%64.06%64.65%70.25%
Operating Margin10.42%9.92%6.39%0.40%-6.77%4.88%
Profit Margin9.36%4.00%-6.30%-30.49%-30.99%-1.53%
Free Cash Flow Margin16.20%12.69%6.59%1.56%-4.89%2.20%
EBITDA80.14M77.64M55.76M28.85M-4.68M41.52M
EBITDA Margin13.77%13.67%9.73%5.63%-0.91%9.64%
D&A For EBITDA19.54M21.30M19.14M26.82M29.97M20.47M
EBIT60.61M56.34M36.63M2.03M-34.66M21.05M
EBIT Margin10.42%9.92%6.39%0.40%-6.77%4.88%
Advertising Expenses4.14M4.42M3.85M5.20M3.87M

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents29.46M51.24M41.58M36.96M30.19M43.93M
Cash & Short-Term Investments30.39M51.24M41.58M36.96M30.19M43.93M
Receivables138.41M128.30M127.39M123.05M136.56M125.05M
Inventory79.81M82.24M92.47M91.33M84.77M61.69M
Prepaid Expenses8.92M11.06M14.16M16.66M18.28M27.16M
Restricted Cash5.28M
Other Current Assets2.78M
Total Current Assets257.53M272.84M275.61M268.00M272.57M263.10M
Property, Plant & Equipment24.75M27.02M33.52M49.96M44.15M40.17M
Long-Term Investments3.51M2.29M1.89M3.14M2.62M29.29M
Goodwill7.46M7.46M7.46M7.46M7.46M147.62M
Other Intangible Assets351.05M368.42M404.73M482.35M639.85M695.19M
Long-Term Deferred Tax Assets29.05M5.52M4.75M481.00K
Other Long-Term Assets405.99M50.00M
Total Assets673.35M683.56M727.96M810.91M1.37B1.23B
Accounts Payable20.20M10.93M23.69M23.04M36.70M16.91M
Accrued Expenses42.79M51.62M65.61M55.45M37.77M66.26M
Current Portion of Long-Term Debt18.75M15.00M27.34M27.85M33.06M18.04M
Current Portion of Leases4.14M4.21M3.92M4.82M3.61M3.50M
Current Income Taxes Payable6.16M5.13M3.87M4.75M2.57M8.14M
Other Current Liabilities60.41M73.49M85.98M59.59M190.31M68.00M
Total Current Liabilities152.45M160.38M210.40M175.50M304.02M180.86M
Long-Term Debt229.70M278.95M308.29M367.00M385.01M339.64M
Long-Term Leases11.15M13.19M16.51M20.96M14.43M15.04M
Long-Term Deferred Tax Liabilities568.00K433.00K564.00K1.21M2.25M133.52M
Other Long-Term Liabilities2.06M2.16M6.59M25.12M254.72M23.01M
Total Liabilities395.93M455.11M542.35M589.79M960.43M692.07M
Common Stock84.00K83.00K82.00K79.00K78.00K75.00K
Additional Paid-In Capital527.92M520.85M508.09M494.25M490.58M465.27M
Retained Earnings-298.38M-334.93M-357.66M-321.54M-165.31M-6.60M
Comprehensive Income & Other-1.33M-1.90M-2.57M794.00K-110.00K179.00K
Total Common Equity228.31M184.10M147.94M173.59M325.24M458.92M
Minority Interest49.11M44.34M37.66M47.53M86.98M74.86M
Shareholders' Equity277.41M228.45M185.60M221.12M412.22M533.79M
Total Liabilities & Equity673.35M683.56M727.96M810.91M1.37B1.23B
Total Debt263.75M311.35M356.06M420.62M436.10M376.22M
Net Cash (Debt)-233.35M-260.11M-314.47M-383.66M-405.92M-332.29M
Net Cash Per Share-3.35-3.77-4.87-6.12-6.61-7.31
Filing Date Shares Outstanding68.31M67.37M66.16M63.38M62.27M60.60M
Total Common Shares Outstanding68.21M67.10M65.76M63.27M62.06M59.55M
Working Capital105.08M112.46M65.21M92.50M-31.44M82.24M
Book Value Per Share3.352.742.252.745.247.71
Tangible Book Value-130.20M-191.78M-264.25M-316.22M-322.07M-383.89M
Tangible Book Value Per Share-1.91-2.86-4.02-5.00-5.19-6.45
Machinery44.73M47.40M44.20M38.07M29.10M
Leasehold Improvements4.34M4.09M3.76M3.35M3.13M

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income54.46M22.73M-36.12M-156.23M-158.70M19.38M
Depreciation & Amortization19.54M21.30M19.14M26.82M29.97M20.47M
Other Amortization3.63M3.63M5.58M6.69M4.45M2.23M
Loss (Gain) From Sale of Assets-1.00K81.00K292.00K3.58M
Asset Writedown & Restructuring Costs36.36M78.61M124.70M
Loss (Gain) From Sale of Investments3.89M1.54M
Stock-Based Compensation14.92M12.67M13.27M2.72M17.59M19.84M
Provision & Write-off of Bad Debts558.00K1.26M-434.00K-1.10M5.19M485.00K
Other Operating Activities7.22M26.84M12.50M59.60M-8.76M-25.80M
Change in Accounts Receivable-6.91M-916.00K-10.67M10.05M-17.67M-20.05M
Change in Inventory13.57M8.57M-16.43M-5.99M-18.62M3.18M
Change in Accounts Payable-8.68M-19.81M17.85M-5.28M-3.10M18.21M
Change in Other Net Operating Assets-1.44M-1.68M-2.52M-1.97M9.66M-16.49M
Operating Cash Flow96.87M74.67M38.80M15.34M-13.54M22.99M
Capital Expenditures-2.59M-2.56M-1.01M-7.36M-11.52M-13.52M
Cash Acquisitions-262.87M
Divestitures-686.00K24.68M34.67M
Sale (Purchase) of Intangibles-709.00K
Investment in Securities-1.50M-7.37M
Other Investing Activities-11.51M-104.92M
Investing Cash Flow-4.09M-3.25M22.96M15.81M-116.44M-283.76M
Long-Term Debt Issued76.91M64.00M104.66M277.45M
Total Debt Issued61.91M76.91M64.00M104.66M277.45M
Long-Term Debt Repaid-54.05M-59.58M-87.26M-45.04M-111.25M
Total Debt Repaid-89.80M-54.05M-59.58M-87.26M-45.04M-111.25M
Net Debt Issued (Repaid)-27.89M22.86M-59.58M-23.26M59.62M166.20M
Issuance of Common Stock1.58M2.07M2.44M778.00K5.82M109.41M
Repurchase of Common Stock-1.35M-9.00K-3.35M
Other Financing Activities-67.34M-87.06M2.56M-4.17M-15.00K-2.24M
Financing Cash Flow-95.00M-62.14M-54.58M-26.65M62.08M273.37M
Foreign Exchange Rate Adjustments-1.24M371.00K-2.56M629.00K521.00K-228.00K
Net Cash Flow-3.45M9.66M4.62M5.13M-67.38M12.37M
Free Cash Flow94.29M72.11M37.79M7.98M-25.06M9.47M
Free Cash Flow Margin16.20%12.69%6.59%1.56%-4.89%2.20%
Free Cash Flow Per Share1.351.050.580.13-0.410.21
Levered Free Cash Flow67.76M28.15M68.24M-108.45M92.14M-25.11M
Unlevered Free Cash Flow80.19M44.71M92.48M-83.02M103.65M-22.71M
Cash Interest Paid27.04M27.04M38.51M32.47M18.04M5.84M
Cash Income Tax Paid2.76M2.76M2.20M1.27M1.52M7.46M
Change in Working Capital-3.46M-13.84M-11.78M-3.18M-29.73M-15.14M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization1.12B498.30M686.36M331.83M161.69M861.26M
Enterprise Value1.35B838.47M1.09B775.33M605.08M1.05B
Last Close Price13.327.4410.505.272.6114.49
PE Ratio17.0421.92
Forward PE16.719.7920.0021.8217.1721.50
PS Ratio1.930.881.200.650.322.00
PB Ratio3.982.183.701.500.391.61
P/FCF Ratio11.886.9118.1641.5790.94
P/OCF Ratio11.576.6717.6921.6337.46
PEG Ratio1.520.810.810.810.812.07
EV/Sales Ratio2.331.481.901.511.182.45
EV/EBITDA Ratio16.8910.8019.4826.8825.38
EV/EBIT Ratio22.3414.8829.66382.6950.07
EV/FCF Ratio14.3611.6328.7597.14111.28
Debt / Equity Ratio0.951.361.921.901.060.70
Debt / EBITDA Ratio3.083.745.7911.81719.648.23
Debt / FCF Ratio2.804.329.4252.7039.72
Net Debt / Equity Ratio0.841.141.691.740.980.62
Net Debt / EBITDA Ratio2.913.355.6413.30-86.708.00
Net Debt / FCF Ratio2.483.618.3248.06-16.2035.09
Asset Turnover0.840.810.740.470.390.50
Inventory Turnover2.072.062.012.092.472.82
Quick Ratio1.111.120.800.910.550.93
Current Ratio1.691.701.311.530.901.46
Return on Equity (ROE)25.68%13.17%-23.14%-38.27%-30.58%3.38%
Return on Assets (ROA)5.49%4.99%2.97%0.12%-1.67%1.53%
Return on Invested Capital (ROIC)12.15%11.40%6.63%0.29%-4.12%3.73%
Return on Capital Employed (ROCE)11.60%10.80%7.10%0.30%-3.20%2.00%
Earnings Yield5.87%4.56%-5.26%-47.08%-98.15%2.25%
FCF Yield8.41%14.47%5.51%2.40%-15.50%1.10%
Buyback Yield / Dilution-5.97%-6.77%-3.03%-2.05%-35.00%-828.01%